Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
IRIS imaging
1 other identifier
observational
4,000
1 country
15
Brief Summary
The purpose of this study is to evaluate the prognosis of coronary stenosis based on intracoronary Imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2016
Longer than P75 for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2016
CompletedFirst Posted
Study publicly available on registry
June 7, 2016
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2030
January 2, 2026
December 1, 2025
10.4 years
June 2, 2016
December 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Target Vessel Failure
defined as composite event of cardiac death, non-fatal myocardiac infarction, target vessel revascularization
2 years
Secondary Outcomes (10)
All-cause death
5 years
Cardiac death
5 years
Number of myocardial infarction events
5 years
Composite event of death or myocardial infarction
5 years
Composite event of cardiac death or myocardial infarction
5 years
- +5 more secondary outcomes
Study Arms (4)
VH-IVUS
Patients with IVUS-derived virtual histology
OCT
Patients with Optical coherence tomography
NIRS
Patients with Near-infrared spectroscopy
gray scale IVUS
Patients with gray-scale IVUS(Intravascular ultrasound)
Interventions
Eligibility Criteria
Patients with intracoronary imaging
You may qualify if:
- Patients with intracoronary imaging
- Written consent
You may not qualify if:
- Severe calcification and/or severe tortuosity
- Lesion with previous bypass graft surgery (CABG)
- Left ventricular ejection fraction less than 30 %
- Coronary spasm
- Life expectancy less than 2 years
- Pregnancy or breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seung-Jung Parklead
- CardioVascular Research Foundation, Koreacollaborator
Study Sites (15)
Asan Medical Center
Seoul, Songpa-gu, 138-736, South Korea
Inje University Busan Paik Hospital
Busan, South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Chungnam National University Hospital
Daejeon, South Korea
Inje University Ilsan Paik Hospital
Ilsan, South Korea
Gachon University Gil Hospital
Incheon, South Korea
Jeju national university hospital
Jeju City, South Korea
Pusan National University Hospital
Pusan, South Korea
Chung-Ang university hospital
Seoul, South Korea
Kangbuk Samsung Hospital
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Ajou University Hospital
Suwon, South Korea
Ulsan University Hospital
Ulsan, South Korea
Wonju Severance Christian Hospital
Wŏnju, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- professor of medicine
Study Record Dates
First Submitted
June 2, 2016
First Posted
June 7, 2016
Study Start
July 1, 2016
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
June 1, 2030
Last Updated
January 2, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
This is not a publicly funded trial.